Measuring the symptom burden associated with the treatment of chronic myeloid leukemia-Reference-Cited by-同舟云学术

Measuring the symptom burden associated with the treatment of chronic myeloid leukemia

Published:2013-08-01 Issue:5 Volume:122 Page:641-647
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Williams Loretta A.¹,Gonzalez Araceli G. Garcia¹,Ault Patricia²,Mendoza Tito R.¹,Sailors Mary L.¹,Williams Janet L.¹,Huang Furong¹,Nazha Aziz²,Kantarjian Hagop M.²,Cleeland Charles S.¹,Cortes Jorge E.²

Affiliation:

1. Department of Symptom Research and

2. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Abstract

Key Points The MD Anderson Symptom Inventory for CML can be used to collect patient-reported symptoms for research and clinical practice. Thirty percent of patients in chronic-phase CML and on TKIs experience moderate symptoms that interfere with daily functioning.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/122/5/641/1373418/641.pdf

Reference35 articles.

1. Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.;Huang;Cancer,2012

3. Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib.;Marin;J Clin Oncol,2010

4. Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: Definitions and clinical implications.;Pinilla-Ibarz;Cancer,2011

5. Phase I trials of molecularly targeted agents: should we pay more attention to late toxicities?;Postel-Vinay;J Clin Oncol,2011

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment Free Remission (TFR) in Chronic Myeloid Leukemia: Successful Achievement of TFR in More Than Two-Third of Patients in a Real-World Practice;Clinical Lymphoma Myeloma and Leukemia;2024-08

2. WeChat assisted electronic symptom measurement for patients with adenomyosis;BMC Medical Informatics and Decision Making;2024-06-17

3. Mutations in Genes Producing Nitric Oxide and Hydrogen Sulfide and Their Connection With Apoptotic Genes in Chronic Myeloid Leukemia;Cureus;2024-06-03

4. The Cardiovascular Event Risk Associated with Tyrosine Kinase Inhibitors and the Lipid Profile in Patients with Chronic Myeloid Leukemia;Hematology Reports;2024-03-12

5. Physical exercise recommendations for patients with chronic myeloid leukemia based on individual preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97);Frontiers in Oncology;2024-02-21